PLK2 and ovarian carcinoma: The Gene Expression Omnibus (GEO) dataset GSE15372 was used to identify PLK2 as a differentially expressed gene (DEG) for drug resistance in ovarian cancer (Figure 3A), and Western blotting and qRT-PCR showed that PLK2 expression was significantly lower in drug-resistant ovarian cells (Figure 3B–D).